{"id":2321,"date":"2026-11-17T17:46:54","date_gmt":"2026-11-17T14:46:54","guid":{"rendered":"https:\/\/tatd.org.tr\/arastirma\/?p=2321"},"modified":"2026-11-17T17:49:58","modified_gmt":"2026-11-17T14:49:58","slug":"sok-rehberi-taslak","status":"publish","type":"post","link":"https:\/\/tatd.org.tr\/arastirma\/2026\/11\/17\/sok-rehberi-taslak\/","title":{"rendered":"Tan\u0131mlanmam\u0131\u015f Non-travmatik Eri\u015fkin \u015eok Y\u00f6netim Rehberi \u2013 2026: Taslak Metin G\u00f6r\u00fc\u015fe A\u00e7\u0131ld\u0131"},"content":{"rendered":"\n<div style=\"text-align:center;margin-bottom:6px;font-size:14px;letter-spacing:2px;color:#c8102e;font-weight:700\">TATD-AKOM KL\u0130N\u0130K UYGULAMA REHBER\u0130 \u00b7 TASLAK MET\u0130N<\/div>\n<p style=\"text-align:center;font-size:15px\"><em>T\u00fcrkiye Acil T\u0131p Derne\u011fi \u2013 Ara\u015ft\u0131rma Komitesi (TATD-AKOM) taraf\u0131ndan 2026 y\u0131l\u0131nda haz\u0131rlanm\u0131\u015ft\u0131r.<\/em><\/p>\n<p style=\"text-align:center;font-size:14px\"><em><strong style=\"color:#000080\">Yazar Komitesi<\/strong><br>Ersin Aksay, G\u00f6khan Aksel, \u015eeref Kerem \u00c7orbac\u0131o\u011flu, Haldun Ako\u011flu, Merve Osoydan Sat\u0131c\u0131, Fatma Nur Karaarslan, Emir \u00dcnal, Yunus Emre \u00d6zl\u00fcer<\/em><\/p>\n\n<div style=\"border:2px solid #c8102e;border-radius:6px;padding:16px 20px;margin:24px 0;background:#fff5f6\">\n<div style=\"font-weight:800;color:#c8102e;letter-spacing:2px;font-size:15px;margin-bottom:6px\">TASLAK MET\u0130N \u00b7 G\u00d6R\u00dc\u015eE A\u00c7IK<\/div>\n<p style=\"margin:0 0 8px\">Bu sayfada yer alan rehber <strong>taslak<\/strong> niteli\u011findedir ve <strong>18 Kas\u0131m 2026<\/strong> tarihinden itibaren <strong>1 ay s\u00fcreyle (18 Kas\u0131m \u2013 18 Aral\u0131k 2026) ask\u0131da<\/strong> kalacakt\u0131r. Ask\u0131 s\u00fcresince meslekta\u015flar\u0131m\u0131zdan gelecek g\u00f6r\u00fc\u015f ve \u00f6neriler y\u00fcr\u00fct\u00fcc\u00fc ekip taraf\u0131ndan de\u011ferlendirilecek; rehberin nihai metni ask\u0131 s\u00fcresinin ard\u0131ndan ayr\u0131ca yay\u0131mlanacakt\u0131r.<\/p>\n<p style=\"margin:0 0 4px;font-size:14px;color:#555\">Taslak metindeki \u00f6neriler ve s\u00fcre hedefleri, nihai metinde de\u011fi\u015fiklik g\u00f6sterebilir. G\u00f6r\u00fc\u015f ve \u00f6nerilerinizi a\u015fa\u011f\u0131daki buton arac\u0131l\u0131\u011f\u0131yla iletebilirsiniz.<\/p>\n<p style=\"text-align:left;margin:14px 0\"><a href=\"https:\/\/tatd.org.tr\/arastirma\/sok-rehberi-oneri-gonder\/\" target=\"_blank\" rel=\"noopener\" style=\"display:inline-flex;align-items:center;gap:10px;background:#e9e9ee;border-radius:40px;padding:6px 8px 6px 6px;text-decoration:none\"><span style=\"width:38px;height:38px;border-radius:50%;background:#fff;display:inline-flex;align-items:center;justify-content:center;color:#d6246e;font-size:18px\">\u270e<\/span><span style=\"background:#d6246e;color:#fff;font-weight:700;border-radius:30px;padding:9px 22px;font-size:16px\">\u00d6neri G\u00f6nder<\/span><\/a><\/p>\n<\/div>\n\n<div style=\"margin:24px 0;border-radius:6px;overflow:hidden;border:1px solid #e3e3e3\">\n<img decoding=\"async\" src=\"https:\/\/tatd.org.tr\/arastirma\/wp-content\/uploads\/sites\/23\/2026\/11\/EACEM2026_banner.jpg\" alt=\"12. Avrasya Acil T\u0131p Kongresi \u2013 22. T\u00fcrkiye Acil T\u0131p Kongresi, 19\u201322 Kas\u0131m 2026, Kaya Palazzo Kongre Merkezi\" style=\"width:100%;height:auto;display:block\">\n<div style=\"padding:14px 18px\">\n<div style=\"font-weight:800;letter-spacing:1px;color:#9b1b30;margin-bottom:6px\">LANSMAN \u00b7 EACEM 2026 PUSULA OTURUMU<\/div>\n<p style=\"margin:0 0 6px\">Rehber, <strong>12. Avrasya Acil T\u0131p Kongresi \/ 22. T\u00fcrkiye Acil T\u0131p Kongresi<\/strong> (EACEM 2026, 19\u201322 Kas\u0131m 2026, Kaya Palazzo Kongre Merkezi) kapsam\u0131nda d\u00fczenlenen <strong>Pusula Oturumu<\/strong>\u2019nda tan\u0131t\u0131lacakt\u0131r.<\/p>\n<ul style=\"margin:0\">\n<li><strong>Tarih ve saat:<\/strong> 20 Kas\u0131m 2026, 09:00\u201310:10<\/li>\n<li><strong>Salon:<\/strong> Salon B<\/li>\n<li><strong>Oturum ba\u015fkanlar\u0131:<\/strong> Murat Ye\u015filaras, G\u00f6khan Aksel<\/li>\n<li><strong>Sunum:<\/strong> <em>Nontravmatik Ayr\u0131mla\u015fmam\u0131\u015f \u015eok Tan\u0131 ve Tedavisinde T\u00fcrkiye Acil T\u0131p Derne\u011fi Delphi Uzla\u015f\u0131 Raporu<\/em> \u2013 Ersin Aksay, Merve Osoydan Sat\u0131c\u0131<\/li>\n<\/ul>\n<\/div>\n<\/div>\n\n\n\n<h3 style=\"background:#2b2b2b;color:#fff;padding:8px 14px\">G\u0130R\u0130\u015e<\/h3>\n<p>Acil servise non-travmatik \u015fok tablosuyla ba\u015fvuran eri\u015fkin hastalarda \u015fokun ard\u0131nda farkl\u0131 organ sistemlerinden kaynaklanan \u00e7ok say\u0131da etiyoloji yatabilir ve hastalar\u0131n \u00f6nemli bir b\u00f6l\u00fcm\u00fcnde ba\u015fvuru an\u0131nda \u015fokun nedeni belli de\u011fildir. Mevcut k\u0131lavuzlar s\u00fcre hedeflerini belirli bir tan\u0131n\u0131n kondu\u011fu hasta gruplar\u0131 i\u00e7in tan\u0131mlamaktad\u0131r; tan\u0131mlanmam\u0131\u015f \u015fokta ise hasta, tan\u0131 konulmadan \u00f6nce de kritik s\u00fcreleri t\u00fcketmekte ve ba\u015fvurudan tan\u0131ya ula\u015f\u0131lana kadar ge\u00e7en s\u00fcre k\u0131lavuzlar\u0131n ortak k\u00f6r noktas\u0131 olarak kalmaktad\u0131r.<\/p>\n<p>Bu rehber, zaman \u00e7izelgesini tan\u0131n\u0131n konuldu\u011fu andan de\u011fil hastan\u0131n ba\u015fvurusundan itibaren tan\u0131mlayan, <strong>be\u015f karar noktas\u0131<\/strong> ve her biri i\u00e7in bir \u00fcst s\u00fcre s\u0131n\u0131r\u0131 i\u00e7eren yap\u0131land\u0131r\u0131lm\u0131\u015f bir yakla\u015f\u0131m sunmaktad\u0131r. \u00d6neriler sekiz hekimden olu\u015fan y\u00fcr\u00fct\u00fcc\u00fc ekip taraf\u0131ndan g\u00fcncel k\u0131lavuzlar ve her \u00f6neri i\u00e7in \u00fc\u00e7 veri taban\u0131nda y\u00fcr\u00fct\u00fclen yap\u0131land\u0131r\u0131lm\u0131\u015f literat\u00fcr taramas\u0131 temelinde haz\u0131rlanm\u0131\u015f, kan\u0131t kesinli\u011fi <strong>GRADE<\/strong> yakla\u015f\u0131m\u0131yla de\u011ferlendirilmi\u015ftir. Uzla\u015f\u0131, 29 uzmandan olu\u015fan panelle iki turlu, \u00e7evrimi\u00e7i, modifiye <strong>Delphi<\/strong> y\u00f6ntemiyle (RAND\/UCLA \u00f6l\u00e7\u00fct\u00fc) sa\u011flanm\u0131\u015f ve s\u00fcre\u00e7 ACCORD 2024 k\u0131lavuzuna uygun bi\u00e7imde raporlanm\u0131\u015ft\u0131r.<\/p>\n<p>Ayr\u0131 ayr\u0131 oylanan 49 maddenin 46\u2019s\u0131nda lehine uzla\u015f\u0131 sa\u011flanm\u0131\u015f, hi\u00e7bir madde aleyhine uzla\u015f\u0131yla elenmemi\u015ftir; uzla\u015f\u0131 sa\u011flanamayan \u00fc\u00e7 madde laboratuvar testlerine (prokalsitonin, CRP ve D-dimer) ili\u015fkindir. Rehber, be\u015f karar noktas\u0131nda toplam <strong>28 \u00f6neri<\/strong> i\u00e7ermektedir. \u00d6nerilerin b\u00fcy\u00fck b\u00f6l\u00fcm\u00fcnde kan\u0131t kesinli\u011fi \u00e7ok d\u00fc\u015f\u00fckt\u00fcr; s\u00fcre hedefleri biyolojik e\u015fikleri de\u011fil, acil servis i\u015f ak\u0131\u015f\u0131nda ula\u015f\u0131labilir kabul edilen <strong>\u00fcst s\u0131n\u0131rlar\u0131<\/strong> yans\u0131tmaktad\u0131r.<\/p>\n<p style=\"color:#bf0474\">NOT: Bu sayfada rehberin yaln\u0131zca karar noktalar\u0131 ve \u00f6neri \u00f6zetleri yer almaktad\u0131r. Rehberin gerek\u00e7eler, kan\u0131t \u00f6zetleri ve Delphi sonu\u00e7lar\u0131n\u0131 i\u00e7eren taslak tam metnini a\u015fa\u011f\u0131daki \u201cRehberin Tamam\u0131\u201d butonunu kullanarak indirebilirsiniz.<\/p>\n\n\n\n<h3 style=\"background:#2b2b2b;color:#fff;padding:8px 14px\">BE\u015e KARAR NOKTASI \u00b7 ZAMAN HEDEFLER\u0130<\/h3>\n<div style=\"display:flex;flex-wrap:wrap;gap:8px;margin:12px 0 8px\">\n<div style=\"flex:1 1 150px;border-top:5px solid #c8102e;background:#f7f7f7;padding:10px\"><div style=\"font-size:20px;font-weight:800;color:#c8102e\">\u2264 15 dk<\/div><div style=\"font-weight:700\">1 \u00b7 Aktivasyon<\/div><div style=\"font-size:13px;color:#555\">Triajdan sonra: de\u011ferlendir, \u015fok protokol\u00fcn\u00fc aktive et<\/div><\/div>\n<div style=\"flex:1 1 150px;border-top:5px solid #e07b00;background:#f7f7f7;padding:10px\"><div style=\"font-size:20px;font-weight:800;color:#e07b00\">\u2264 10 dk<\/div><div style=\"font-weight:700\">2 \u00b7 Erken nedenler<\/div><div style=\"font-size:13px;color:#555\">Zamana duyarl\u0131 nedenleri tan\u0131 ve tedavi et<\/div><\/div>\n<div style=\"flex:1 1 150px;border-top:5px solid #00857c;background:#f7f7f7;padding:10px\"><div style=\"font-size:20px;font-weight:800;color:#00857c\">\u2264 30 dk<\/div><div style=\"font-weight:700\">3 \u00b7 POCUS<\/div><div style=\"font-size:13px;color:#555\">Odaklanm\u0131\u015f POCUS protokol\u00fcn\u00fc tamamla ve tedavi et<\/div><\/div>\n<div style=\"flex:1 1 150px;border-top:5px solid #2f5fb3;background:#f7f7f7;padding:10px\"><div style=\"font-size:20px;font-weight:800;color:#2f5fb3\">\u2264 60 dk<\/div><div style=\"font-weight:700\">4 \u00b7 Laboratuvar<\/div><div style=\"font-size:13px;color:#555\">Sonu\u00e7lar\u0131 elde et; olas\u0131 septik \u015fokta antibiyotik<\/div><\/div>\n<div style=\"flex:1 1 150px;border-top:5px solid #6b3fa0;background:#f7f7f7;padding:10px\"><div style=\"font-size:20px;font-weight:800;color:#6b3fa0\">\u2264 90 dk<\/div><div style=\"font-weight:700\">5 \u00b7 T\u00fcm v\u00fccut BT<\/div><div style=\"font-size:13px;color:#555\">Etiyoloji h\u00e2l\u00e2 yoksa beyin + toraks + bat\u0131n BT<\/div><\/div>\n<\/div>\n<p style=\"font-size:14px\">Karar noktas\u0131 1\u2019in s\u00fcresi triaj ba\u015fvurusundan, karar noktas\u0131 2\u20135\u2019in s\u00fcreleri ise <strong>\u015fok protokol\u00fc aktivasyonundan<\/strong> (kronometrenin s\u0131f\u0131rland\u0131\u011f\u0131 an) itibaren hesaplan\u0131r. <strong>S\u00fcreler hedef de\u011fil, \u00fcst s\u0131n\u0131rd\u0131r:<\/strong> her ad\u0131m m\u00fcmk\u00fcn olan en k\u0131sa s\u00fcrede tamamlanmal\u0131, belirtilen s\u00fcre a\u015f\u0131lmamal\u0131d\u0131r.<\/p>\n<p style=\"font-size:14px\"><strong>Kan\u0131t kesinli\u011fi (GRADE):<\/strong> \u2a01\u2a01\u2a01\u2a01 Y\u00fcksek \u00b7 \u2a01\u2a01\u2a01\u25ef Orta \u00b7 \u2a01\u2a01\u25ef\u25ef D\u00fc\u015f\u00fck \u00b7 \u2a01\u25ef\u25ef\u25ef \u00c7ok d\u00fc\u015f\u00fck &nbsp;|&nbsp; <strong>\u00d6neri g\u00fcc\u00fc:<\/strong> G\u00fc\u00e7l\u00fc \u00b7 Orta \u00b7 Zay\u0131f<\/p>\n\n\n<div style=\"margin:36px 0 10px;border-left:6px solid #c8102e;padding:10px 16px;background:#f7f7f7\"><div style=\"font-size:13px;letter-spacing:2px;color:#c8102e;font-weight:700\">KARAR NOKTASI 1 \u00b7 \u00d6neri 1\u20135<\/div><h3 style=\"margin:4px 0 6px\">Ba\u015fvuru \u2013 \u015eok Karar\u0131 Zaman\u0131<\/h3><div style=\"font-size:15px\"><strong style=\"color:#c8102e;font-size:18px\">\u2264 15 dk<\/strong> <span style=\"color:#555\">(triyaj ba\u015fvurusundan itibaren)<\/span><\/div><\/div>\n<p><strong>Temel hedef:<\/strong> Acil servise ba\u015fvuran kritik g\u00f6r\u00fcn\u00fcml\u00fc non-travmatik eri\u015fkin hastada \u015fok protokol\u00fc aktivasyonu yap\u0131l\u0131p yap\u0131lmayaca\u011f\u0131na karar verilmesi. Aktivasyon an\u0131nda kronometre s\u0131f\u0131rlan\u0131r; sonraki t\u00fcm s\u00fcre hedefleri bu andan itibaren i\u015fler.<\/p>\n\n<div><div class=\"pcrstb-wrap\"><table style=\"width:100%;border-collapse:collapse;font-size:14px;line-height:1.45\"><thead><tr><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\" width=\"7%\">\u00d6neri<\/th><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\">\u00d6neri metni<\/th><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\" width=\"11%\">S\u00fcre hedefi<\/th><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\" width=\"12%\">Kan\u0131t kesinli\u011fi<\/th><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\" width=\"10%\">\u00d6neri g\u00fcc\u00fc<\/th><\/tr><\/thead><tbody>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>1<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">Kritik g\u00f6r\u00fcn\u00fcml\u00fc hastalara triyajda \u00f6ncelik tan\u0131nmal\u0131, h\u0131zla monit\u00f6rize edilmeli, vital bulgular\u0131 (kan bas\u0131nc\u0131, kalp h\u0131z\u0131, solunum say\u0131s\u0131, periferik oksijen sat\u00fcrasyonu, v\u00fccut \u0131s\u0131s\u0131) \u00f6l\u00e7\u00fclmeli, odaklanm\u0131\u015f \u00f6yk\u00fc ve muayene (bilin\u00e7, havayolu, solunum, dola\u015f\u0131m, kapiller dolum zaman\u0131) tamamlanmal\u0131 ve damar yolu a\u00e7\u0131lmal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226415 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#1e7d32;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">G\u00fc\u00e7l\u00fc<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>2<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">Bilinci bask\u0131l\u0131 hastalarda yatak ba\u015f\u0131 kan \u015fekeri h\u0131zla \u00f6l\u00e7\u00fclmelidir.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226415 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#1e7d32;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">G\u00fc\u00e7l\u00fc<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>3<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">Kan gaz\u0131 analizinin (arteriyel\/ven\u00f6z) sonucu de\u011ferlendirilmelidir.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226415 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#1e7d32;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">G\u00fc\u00e7l\u00fc<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>4<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">Ba\u015fvurunun ilk 10 dakikas\u0131 i\u00e7inde 12 derivasyonlu EKG \u00e7ekilmi\u015f ve yorumlanm\u0131\u015f olmal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226410 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#1e7d32;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">G\u00fc\u00e7l\u00fc<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>5<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">\u00d6yk\u00fc, vital bulgular, muayene, EKG ve gerekli olgularda kan gaz\u0131 analizi sonucu de\u011ferlendirilerek, \u015fok y\u00f6netim algoritmas\u0131n\u0131n aktive edilip edilmeyece\u011fine karar verilmelidir. \u015eok y\u00f6netim algoritmas\u0131n\u0131n aktivasyonu olabildi\u011fince erken yap\u0131lmal\u0131d\u0131r, a\u00e7\u0131k \u015fok bulgular\u0131 sergileyen hastalarda kan gaz\u0131 analiz sonucu beklenmeden de aktivasyon yap\u0131labilir.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226415 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#1e7d32;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">G\u00fc\u00e7l\u00fc<\/span><\/td><\/tr>\n<\/tbody><\/table><\/div><\/div>\n\n<p style=\"font-size:13px;color:#555\">Bu karar noktas\u0131ndaki s\u00fcreler acil servis triyaj ba\u015fvurusundan itibaren hesaplan\u0131r. EKG: elektrokardiyografi.<\/p>\n\n\n\n<div style=\"margin:36px 0 10px;border-left:6px solid #e07b00;padding:10px 16px;background:#f7f7f7\"><div style=\"font-size:13px;letter-spacing:2px;color:#e07b00;font-weight:700\">KARAR NOKTASI 2 \u00b7 \u00d6neri 6\u201315<\/div><h3 style=\"margin:4px 0 6px\">Aktivasyonun \u0130lk 10 Dakikas\u0131 \u2013 Erken Tan\u0131nabilen Nedenler<\/h3><div style=\"font-size:15px\"><strong style=\"color:#e07b00;font-size:18px\">\u2264 10 dk<\/strong> <span style=\"color:#555\">(\u015fok protokol\u00fc aktivasyonundan itibaren)<\/span><\/div><\/div>\n<p><strong>Temel hedef:<\/strong> \u00d6yk\u00fc, vital bulgular, kapsaml\u0131 fizik muayene, EKG ve kan gaz\u0131 sonu\u00e7lar\u0131yla anafilaksi, STEMI, instabil ta\u015fi\/bradiaritmi, opiyat toksisitesi, solunum yetmezli\u011fi ve akut kan kayb\u0131 gibi zamana duyarl\u0131 nedenlerin tan\u0131nmas\u0131 ve tedavilerinin ba\u015flat\u0131lmas\u0131.<\/p>\n\n<div><div class=\"pcrstb-wrap\"><table style=\"width:100%;border-collapse:collapse;font-size:14px;line-height:1.45\"><thead><tr><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\" width=\"7%\">\u00d6neri<\/th><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\">\u00d6neri metni<\/th><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\" width=\"11%\">S\u00fcre hedefi<\/th><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\" width=\"12%\">Kan\u0131t kesinli\u011fi<\/th><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\" width=\"10%\">\u00d6neri g\u00fcc\u00fc<\/th><\/tr><\/thead><tbody>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>6<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">Semptoma y\u00f6nelik detayl\u0131 fizik muayene en k\u0131sa s\u00fcrede tamamlanmal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226410 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#1e7d32;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">G\u00fc\u00e7l\u00fc<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>7<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">Anafilaksi tan\u0131sal kriterleri de\u011ferlendirilmeli, anafilaksi tan\u0131sal kriterlerini kar\u015f\u0131layan hastalara uyluk \u00fcst-d\u0131\u015f k\u0131sm\u0131ndan intram\u00fcsk\u00fcler epinefrin uygulanmal\u0131d\u0131r. Epinefrin uygulamas\u0131 olabilen en k\u0131sa s\u00fcrede tamamlanmal\u0131, \u015fok aktivasyonundan sonraki 10 dakika a\u015f\u0131lmamal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226410 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#1e7d32;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">G\u00fc\u00e7l\u00fc<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>8<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">EKG&#x27;de STEMI veya STEMI-e\u015fde\u011feri bulgu saptanan hastalarda reperf\u00fczyon karar\u0131 verilmelidir. Reperf\u00fczyon karar\u0131 olabilen en k\u0131sa s\u00fcrede al\u0131nmal\u0131, \u015fok aktivasyonundan sonraki 10 dakika a\u015f\u0131lmamal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226410 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u2a01\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">D\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#1e7d32;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">G\u00fc\u00e7l\u00fc<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>9<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">Fibrinoliz karar\u0131 verilen hastalarda, ekokardiyografi ile \u015foka neden olabilecek mekanik komplikasyonlar d\u0131\u015flanmal\u0131d\u0131r. Fibrinolitik tedavi olabilen en k\u0131sa s\u00fcrede ba\u015flanmal\u0131d\u0131r, ancak ekokardiyografinin tamamlanmas\u0131 i\u00e7in gerekli ek s\u00fcre de g\u00f6z \u00f6n\u00fcne al\u0131narak \u015fok aktivasyonundan sonraki 20 dakika a\u015f\u0131lmamal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226420 dakika\u2020<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#b26a00;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">Orta<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>10<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">\u015eoka neden oldu\u011fu d\u00fc\u015f\u00fcn\u00fclen akut ta\u015fidisritmiler tan\u0131nmal\u0131, elektriksel kardiyoversiyon uygulanmal\u0131d\u0131r. Elektriksel kardiyoversiyon en k\u0131sa s\u00fcrede tamamlanmal\u0131, \u015fok aktivasyonundan sonraki 10 dakika a\u015f\u0131lmamal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226410 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#1e7d32;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">G\u00fc\u00e7l\u00fc<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>11<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">Hemodinamik bozulmaya yol a\u00e7an instabil bradikardiler tan\u0131nmal\u0131, tedavisi i\u00e7in semptomatik bradikardi algoritmas\u0131 ba\u015flat\u0131lmal\u0131d\u0131r. Atropin, inotrop, kronotrop, vazopres\u00f6r, pacemaker gibi spesifik tedaviler en k\u0131sa s\u00fcrede ba\u015flanmal\u0131, \u015fok aktivasyonundan sonraki 10 dakika a\u015f\u0131lmamal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226410 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#1e7d32;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">G\u00fc\u00e7l\u00fc<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>12<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">Opiyat toksisitesi bulgular\u0131 de\u011ferlendirilmeli ve toksisite d\u00fc\u015f\u00fcn\u00fclen hastalarda nalokson en k\u0131sa s\u00fcrede verilmeli, \u015fok aktivasyonundan sonraki 10 dakika a\u015f\u0131lmamal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226410 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#1e7d32;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">G\u00fc\u00e7l\u00fc<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>13<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">Kan gaz\u0131nda saptanan ya\u015fam\u0131 tehdit edici patolojiler tespit edilmeli ve spesifik tedavileri en k\u0131sa s\u00fcrede ba\u015flat\u0131lmal\u0131, \u015fok aktivasyonundan sonraki 10 dakika a\u015f\u0131lmamal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226410 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#1e7d32;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">G\u00fc\u00e7l\u00fc<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>14<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">Solunum yetmezli\u011fi bulgular\u0131 sergileyen, kan gaz\u0131 incelemesinde hipoksi\/hiperkarbi saptanan hastalarda uygun solunum deste\u011fi ve oksijenasyon (IMV, NIMV, HFNO vb.) en k\u0131sa s\u00fcrede ba\u015flamal\u0131, \u015fok aktivasyonundan sonraki 10 dakika a\u015f\u0131lmamal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226410 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#b26a00;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">Orta<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>15<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">\u015eok nedeninin akut kan kayb\u0131 oldu\u011fu d\u00fc\u015f\u00fcn\u00fclen hastalar i\u00e7in kan transf\u00fczyon planlamas\u0131 en k\u0131sa s\u00fcrede yap\u0131lmal\u0131, \u015fok aktivasyonundan sonraki 10 dakika a\u015f\u0131lmamal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226410 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#1e7d32;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">G\u00fc\u00e7l\u00fc<\/span><\/td><\/tr>\n<\/tbody><\/table><\/div><\/div>\n\n<p style=\"font-size:13px;color:#555\">\u2020 Fibrinolitik tedavi i\u00e7in \u00fcst s\u0131n\u0131r, ekokardiyografinin tamamlanmas\u0131 i\u00e7in gereken ek s\u00fcre g\u00f6z \u00f6n\u00fcne al\u0131narak 20 dakika olarak belirlenmi\u015ftir. STEMI: ST segment y\u00fckselmeli miyokart enfarkt\u00fcs\u00fc; IMV\/NIMV: invaziv\/non-invaziv mekanik ventilasyon; HFNO: y\u00fcksek ak\u0131ml\u0131 nazal oksijen.<\/p>\n\n\n\n<div style=\"margin:36px 0 10px;border-left:6px solid #00857c;padding:10px 16px;background:#f7f7f7\"><div style=\"font-size:13px;letter-spacing:2px;color:#00857c;font-weight:700\">KARAR NOKTASI 3 \u00b7 \u00d6neri 16\u201324<\/div><h3 style=\"margin:4px 0 6px\">Aktivasyonun \u0130lk 30 Dakikas\u0131 \u2013 POCUS<\/h3><div style=\"font-size:15px\"><strong style=\"color:#00857c;font-size:18px\">\u2264 30 dk<\/strong> <span style=\"color:#555\">(\u015fok protokol\u00fc aktivasyonundan itibaren)<\/span><\/div><\/div>\n<p><strong>Temel hedef:<\/strong> Nedeni h\u00e2l\u00e2 belirsiz olgularda yatak ba\u015f\u0131 odaklanm\u0131\u015f ultrasonografi (POCUS) protokol\u00fcn\u00fcn tamamlanmas\u0131, saptanan nedenlerin (obstr\u00fcktif, kardiyojenik, hipovolemik, septik) tedavisi ve kardiyak arrest e\u015fi\u011findeki hastalarda neden netle\u015fmeden hemodinamik deste\u011fin ba\u015flat\u0131lmas\u0131.<\/p>\n\n<div><div class=\"pcrstb-wrap\"><table style=\"width:100%;border-collapse:collapse;font-size:14px;line-height:1.45\"><thead><tr><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\" width=\"7%\">\u00d6neri<\/th><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\">\u00d6neri metni<\/th><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\" width=\"11%\">S\u00fcre hedefi<\/th><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\" width=\"12%\">Kan\u0131t kesinli\u011fi<\/th><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\" width=\"10%\">\u00d6neri g\u00fcc\u00fc<\/th><\/tr><\/thead><tbody>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>16<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">\u00dc\u00e7\u00fcnc\u00fc karar noktas\u0131na kadar \u015fok etiyolojisi ayd\u0131nlat\u0131lmam\u0131\u015f hastalarda POCUS (RUSH protokol\u00fc gibi) en k\u0131sa s\u00fcrede tamamlanmal\u0131, \u015fok aktivasyonundan sonraki 30 dakika a\u015f\u0131lmamal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226430 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#b26a00;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">Orta<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>17a<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">POCUS protokol\u00fc ile \u015foku a\u00e7\u0131klayacak ba\u015fka neden bulunmayan, akut oldu\u011fu d\u00fc\u015f\u00fcn\u00fclen RV yetmezlik bulgusu sergileyen, a\u011f\u0131r hemodinamik bozulma nedeniyle BT anjiyografiye transport edilemeyen hastalar, y\u00fcksek olas\u0131l\u0131kl\u0131 PE olarak kabul edilerek reperf\u00fczyon uygulanmas\u0131 d\u00fc\u015f\u00fcn\u00fclebilir.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">Endikasyon \u00f6nerisi<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#8a8a8a;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">Zay\u0131f<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>17b<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">POCUS protokol\u00fc ile \u015foku a\u00e7\u0131klayacak ba\u015fka neden bulunmayan, akut oldu\u011fu d\u00fc\u015f\u00fcn\u00fclen RV yetmezlik bulgusu sergileyen, a\u011f\u0131r hemodinamik bozulma nedeniyle BT anjiyografiye transport edilemeyen hastalar, y\u00fcksek olas\u0131l\u0131kl\u0131 PE olarak kabul edilerek en k\u0131sa s\u00fcrede reperf\u00fczyon karar\u0131 al\u0131nmal\u0131, reperf\u00fczyon karar\u0131n\u0131n verilmesi \u015fok aktivasyonundan sonraki 30 dakikay\u0131 ge\u00e7memelidir.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226430 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#8a8a8a;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">Zay\u0131f<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>18<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">POCUS protokol\u00fc sonras\u0131nda akut PE d\u00fc\u015f\u00fcn\u00fclen, hipotansif hastalarda hemodinamik destek i\u00e7in vazopres\u00f6r ve\/veya inotrop tedavi (norepinefrin\/dobutamin) en k\u0131sa s\u00fcrede ba\u015flanmal\u0131, \u015fok aktivasyonundan sonraki 30 dakika a\u015f\u0131lmamal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226430 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#1e7d32;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">G\u00fc\u00e7l\u00fc<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>19<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">POCUS protokol\u00fc ile sol kalp yetmezli\u011fi ve hipervolemi d\u0131\u015flanm\u0131\u015f hastalarda kristaloid res\u00fcsitasyonu en k\u0131sa s\u00fcrede ba\u015flanmal\u0131, tedavi ba\u015flang\u0131c\u0131 \u015fok aktivasyonundan sonraki 30 dakikay\u0131 a\u015fmamal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226430 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#b26a00;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">Orta<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>20a<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">Olas\u0131 septik \u015fok d\u00fc\u015f\u00fcn\u00fclen, kardiyak arrest e\u015fi\u011findeki kritik hastalara, s\u0131v\u0131 yan\u0131t\u0131 beklenmeden norepinefrin inf\u00fczyonu ba\u015flanmas\u0131 d\u00fc\u015f\u00fcn\u00fclebilir.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">Endikasyon \u00f6nerisi<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u2a01\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">D\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#b26a00;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">Orta<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>20b<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">Olas\u0131 septik \u015fok d\u00fc\u015f\u00fcn\u00fclen, kardiyak arrest e\u015fi\u011findeki kritik hastalara, s\u0131v\u0131 yan\u0131t\u0131 beklenmeden norepinefrin inf\u00fczyonu en k\u0131sa s\u00fcrede ba\u015flanmal\u0131, tedavi ba\u015flang\u0131c\u0131 \u015fok aktivasyonundan sonraki 30 dakikay\u0131 a\u015fmamal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226430 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#b26a00;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">Orta<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>21a<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">Septik \u015fok d\u00fc\u015f\u00fcn\u00fclmeyen kardiyak arrest e\u015fi\u011findeki di\u011fer kritik hastalarda, s\u0131v\u0131 yan\u0131t\u0131 beklenmeden norepinefrin inf\u00fczyonu ba\u015flat\u0131lmas\u0131 d\u00fc\u015f\u00fcn\u00fclebilir.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">Endikasyon \u00f6nerisi<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#8a8a8a;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">Zay\u0131f<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>21b<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">Septik \u015fok d\u00fc\u015f\u00fcn\u00fclmeyen kardiyak arrest e\u015fi\u011findeki di\u011fer kritik hastalarda, s\u0131v\u0131 yan\u0131t\u0131 beklenmeden norepinefrin inf\u00fczyonu en k\u0131sa s\u00fcrede ba\u015flanmal\u0131, tedavi ba\u015flang\u0131c\u0131 \u015fok aktivasyonundan sonraki 30 dakikay\u0131 a\u015fmamal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226430 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#8a8a8a;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">Zay\u0131f<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>22<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">POCUS protokol\u00fc sonras\u0131nda kardiyojenik \u015fok bulgular\u0131 varl\u0131\u011f\u0131nda vazopres\u00f6r\/inotrop inf\u00fczyonu (norepinefrin vb.) en k\u0131sa s\u00fcrede ba\u015flanmal\u0131, tedavi ba\u015flang\u0131c\u0131 \u015fok aktivasyonundan sonraki 30 dakikay\u0131 a\u015fmamal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226430 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#1e7d32;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">G\u00fc\u00e7l\u00fc<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>23<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">POCUS protokol\u00fcnde tansiyon pn\u00f6motoraks tespit edilen hastalarda dekompresyon giri\u015fimi en k\u0131sa s\u00fcrede ba\u015flanmal\u0131, \u015fok aktivasyonundan sonraki 30 dakika a\u015f\u0131lmamal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226430 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#1e7d32;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">G\u00fc\u00e7l\u00fc<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>24<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">POCUS protokol\u00fcnde perikardiyal tamponad tespit edilen hastalarda dekompresyon giri\u015fimi en k\u0131sa s\u00fcrede ba\u015flanmal\u0131, \u015fok aktivasyonundan sonraki 30 dakika a\u015f\u0131lmamal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226430 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#1e7d32;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">G\u00fc\u00e7l\u00fc<\/span><\/td><\/tr>\n<\/tbody><\/table><\/div><\/div>\n\n<p style=\"font-size:13px;color:#555\">\u201ca\u201d \u00f6nerileri giri\u015fimin endikasyonunu, \u201cb\u201d \u00f6nerileri s\u00fcre hedefini tan\u0131mlar. POCUS: yatak ba\u015f\u0131 odaklanm\u0131\u015f ultrasonografi; RUSH: Rapid Ultrasound in Shock; RV: sa\u011f ventrik\u00fcl; PE: pulmoner emboli.<\/p>\n\n\n\n<div style=\"margin:36px 0 10px;border-left:6px solid #2f5fb3;padding:10px 16px;background:#f7f7f7\"><div style=\"font-size:13px;letter-spacing:2px;color:#2f5fb3;font-weight:700\">KARAR NOKTASI 4 \u00b7 \u00d6neri 25\u201326b<\/div><h3 style=\"margin:4px 0 6px\">Aktivasyonun \u0130lk 60 Dakikas\u0131 \u2013 Laboratuvar ve Olas\u0131 Septik \u015eok<\/h3><div style=\"font-size:15px\"><strong style=\"color:#2f5fb3;font-size:18px\">\u2264 60 dk<\/strong> <span style=\"color:#555\">(\u015fok protokol\u00fc aktivasyonundan itibaren)<\/span><\/div><\/div>\n<p><strong>Temel hedef:<\/strong> Kapsaml\u0131 laboratuvar sonu\u00e7lar\u0131n\u0131n elde edilip tedavi karar\u0131na d\u00f6n\u00fc\u015ft\u00fcr\u00fclmesi; ba\u015fka bir neden saptanamayan hastalarda olas\u0131 septik \u015fok kabul\u00fc, k\u00fclt\u00fcrlerin al\u0131nmas\u0131 ve ampirik parenteral antibiyotik tedavisinin ba\u015flat\u0131lmas\u0131.<\/p>\n\n<div><div class=\"pcrstb-wrap\"><table style=\"width:100%;border-collapse:collapse;font-size:14px;line-height:1.45\"><thead><tr><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\" width=\"7%\">\u00d6neri<\/th><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\">\u00d6neri metni<\/th><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\" width=\"11%\">S\u00fcre hedefi<\/th><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\" width=\"12%\">Kan\u0131t kesinli\u011fi<\/th><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\" width=\"10%\">\u00d6neri g\u00fcc\u00fc<\/th><\/tr><\/thead><tbody>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>25<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">Kapsaml\u0131 laboratuvar test sonu\u00e7lar\u0131 en k\u0131sa s\u00fcrede elde edilmelidir, test sonu\u00e7lar\u0131n\u0131n elde edilip de\u011ferlendirilmesi \u015fok aktivasyonundan sonraki 60 dakikay\u0131 a\u015fmamal\u0131d\u0131r.<br><span style=\"font-size:13px;color:#333\"><strong>Lehine uzla\u015f\u0131 sa\u011flanan testler:<\/strong> tam kan say\u0131m\u0131, glukoz, sodyum, potasyum, klor, kalsiyum, magnezyum, karaci\u011fer fonksiyon testleri, b\u00f6brek fonksiyon testleri, y\u00fcksek duyarl\u0131kl\u0131 troponin, tam idrar tetkiki, BNP, INR, lipaz.<br><strong>Uzla\u015f\u0131 sa\u011flanamayan testler:<\/strong> prokalsitonin, CRP, D-dimer.<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226460 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#b26a00;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">Orta<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>26a<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">\u00d6yk\u00fc, vital bulgular, fizik muayene, EKG, POCUS protokol\u00fc ve laboratuvar testleri ile \u015foku a\u00e7\u0131klayacak ba\u015fka bir neden saptanamayan hastalar, olas\u0131 septik \u015fok kabul edilerek, ilgili k\u00fclt\u00fcrler al\u0131nmal\u0131 ve ampirik parenteral antibiyotik tedavisi ba\u015flanmal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">Endikasyon \u00f6nerisi<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#b26a00;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">Orta<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>26b<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">\u00d6yk\u00fc, vital bulgu, fizik muayene, EKG, POCUS protokol\u00fc ve laboratuvar testleri ile \u015foku a\u00e7\u0131klayacak spesifik bir neden saptanamayan hastalar, olas\u0131 septik \u015fok kabul edilip en k\u0131sa s\u00fcrede ilgili k\u00fclt\u00fcrler al\u0131nmal\u0131 ve ampirik parenteral antibiyotik tedavisi ba\u015flanmal\u0131, \u015fok aktivasyonundan sonraki 60 dakika a\u015f\u0131lmamal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226460 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#1e7d32;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">G\u00fc\u00e7l\u00fc<\/span><\/td><\/tr>\n<\/tbody><\/table><\/div><\/div>\n\n<p style=\"font-size:13px;color:#555\">Delphi s\u00fcrecinde ayr\u0131 ayr\u0131 oylanan 17 laboratuvar testi rehberde tek bir \u00f6neri (\u00d6neri 25) alt\u0131nda toplanm\u0131\u015ft\u0131r. \u201ca\u201d \u00f6nerisi endikasyonu, \u201cb\u201d \u00f6nerisi s\u00fcre hedefini tan\u0131mlar.<\/p>\n\n\n\n<div style=\"margin:36px 0 10px;border-left:6px solid #6b3fa0;padding:10px 16px;background:#f7f7f7\"><div style=\"font-size:13px;letter-spacing:2px;color:#6b3fa0;font-weight:700\">KARAR NOKTASI 5 \u00b7 \u00d6neri 27\u201328<\/div><h3 style=\"margin:4px 0 6px\">Aktivasyonun \u0130lk 90 Dakikas\u0131 \u2013 T\u00fcm V\u00fccut BT<\/h3><div style=\"font-size:15px\"><strong style=\"color:#6b3fa0;font-size:18px\">\u2264 90 dk<\/strong> <span style=\"color:#555\">(\u015fok protokol\u00fc aktivasyonundan itibaren)<\/span><\/div><\/div>\n<p><strong>Temel hedef:<\/strong> T\u00fcm basamaklara ra\u011fmen etiyolojisi saptanamayan olgularda beyin, toraks ve bat\u0131n\u0131 kapsayan t\u00fcm v\u00fccut BT protokol\u00fcn\u00fcn tamamlanmas\u0131 ve de\u011ferlendirilmesi.<\/p>\n\n<div><div class=\"pcrstb-wrap\"><table style=\"width:100%;border-collapse:collapse;font-size:14px;line-height:1.45\"><thead><tr><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\" width=\"7%\">\u00d6neri<\/th><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\">\u00d6neri metni<\/th><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\" width=\"11%\">S\u00fcre hedefi<\/th><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\" width=\"12%\">Kan\u0131t kesinli\u011fi<\/th><th style=\"border:1px solid #ddd;padding:8px;background:#2b2b2b;color:#fff;text-align:left;font-weight:600\" width=\"10%\">\u00d6neri g\u00fcc\u00fc<\/th><\/tr><\/thead><tbody>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>27<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">Bu a\u015famaya kadar etiyolojisi saptanamayan hastalarda t\u00fcm v\u00fccut BT protokol\u00fc en k\u0131sa s\u00fcrede tamamlanmal\u0131d\u0131r. BT protokol\u00fcn\u00fcn de\u011ferlendirilerek olas\u0131 \u015fok nedenlerinin tan\u0131nmas\u0131, \u015fok aktivasyonundan sonraki 90 dakikay\u0131 a\u015fmamal\u0131d\u0131r.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226490 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#1e7d32;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">G\u00fc\u00e7l\u00fc<\/span><\/td><\/tr>\n<tr><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><strong>28<\/strong><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top\">T\u00fcm v\u00fccut BT protokol\u00fcndeki toraks ve bat\u0131n BT, intraven\u00f6z kontrast madde kullan\u0131larak \u00e7ekilmelidir.<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\">\u226490 dakika<\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"white-space:nowrap\">\u2a01\u25ef\u25ef\u25ef<\/span><br><span style=\"font-size:12px\">\u00c7ok d\u00fc\u015f\u00fck<\/span><\/td><td style=\"border:1px solid #ddd;padding:8px;vertical-align:top;text-align:center\"><span style=\"display:inline-block;padding:2px 8px;border-radius:3px;background:#b26a00;color:#fff;font-size:12px;font-weight:600;white-space:nowrap\">Orta<\/span><\/td><\/tr>\n<\/tbody><\/table><\/div><\/div>\n\n\n<h3 style=\"background:#2b2b2b;color:#fff;padding:8px 14px;margin-top:36px\">REHBER\u0130N TAMAMI (TASLAK)<\/h3>\n<p>\u00d6nerilerin gerek\u00e7eleri, mevcut kan\u0131tlar\u0131n \u00f6zetleri, GRADE de\u011ferlendirmeleri ve Delphi uzla\u015f\u0131 raporunu i\u00e7eren taslak tam metni tek dosya h\u00e2linde indirmek i\u00e7in a\u015fa\u011f\u0131daki butonu t\u0131klay\u0131n.<\/p>\n<p style=\"text-align:center\"><a href=\"https:\/\/tatd.org.tr\/arastirma\/wp-content\/uploads\/sites\/23\/2026\/11\/TATD_Sok_Rehberi_Taslak_2026_v2.pdf\" target=\"_blank\" rel=\"noopener\"><img decoding=\"async\" src=\"https:\/\/tatd.org.tr\/arastirma\/wp-content\/uploads\/sites\/23\/2024\/08\/RehberintamamiTR-1024x331.png\" alt=\"Rehberin Tamam\u0131 (Taslak) \u2013 PDF\" style=\"max-width:420px;width:100%;height:auto\"><\/a><\/p>\n<div style=\"max-width:420px;margin:18px auto 10px;border:2px solid #D91E3E;border-radius:8px;padding:14px 18px;text-align:center;background:#fff\"><div style=\"font-size:13px;letter-spacing:2px;color:#D91E3E;font-weight:700\">CEP REHBER\u0130 \u00b7 A6<\/div><div style=\"font-size:14px;color:#555;margin:4px 0 10px\">Be\u015f karar noktas\u0131 ve \u00f6nerilerin cepte ta\u015f\u0131nabilir \u00f6zeti<\/div><a href=\"https:\/\/tatd.org.tr\/arastirma\/wp-content\/uploads\/sites\/23\/2026\/11\/TATD_Sok_Algoritmasi_2026_Cep_Rehberi_A6_GRADE_v10.pdf\" target=\"_blank\" rel=\"noopener\" style=\"display:inline-block;background:#D91E3E;color:#fff;font-weight:700;padding:10px 22px;border-radius:30px;text-decoration:none\">Cep rehberi i\u00e7in t\u0131klay\u0131n<\/a><\/div>\n<p style=\"font-size:13px;color:#555;text-align:center\">Taslak metin \u00b7 Ask\u0131 s\u00fcresi: 18 Kas\u0131m \u2013 18 Aral\u0131k 2026 \u00b7 Nihai metin ask\u0131 s\u00fcresinin ard\u0131ndan yay\u0131mlanacakt\u0131r.<\/p>\n<h3 style=\"background:#2b2b2b;color:#fff;padding:8px 14px;margin-top:30px\">G\u00d6R\u00dc\u015e VE \u00d6NER\u0130LER\u0130N\u0130Z<\/h3>\n<p>Taslak rehbere ili\u015fkin g\u00f6r\u00fc\u015f ve \u00f6nerilerinizi 18 Aral\u0131k 2026 tarihine kadar a\u015fa\u011f\u0131daki form arac\u0131l\u0131\u011f\u0131yla iletebilirsiniz. L\u00fctfen g\u00f6r\u00fc\u015f\u00fcn\u00fcz\u00fcn ilgili oldu\u011fu karar noktas\u0131n\u0131 ve \u00f6neri numaras\u0131n\u0131 belirtiniz.<\/p>\n<p style=\"text-align:center;margin:14px 0\"><a href=\"https:\/\/tatd.org.tr\/arastirma\/sok-rehberi-oneri-gonder\/\" target=\"_blank\" rel=\"noopener\" style=\"display:inline-flex;align-items:center;gap:10px;background:#e9e9ee;border-radius:40px;padding:6px 8px 6px 6px;text-decoration:none\"><span style=\"width:38px;height:38px;border-radius:50%;background:#fff;display:inline-flex;align-items:center;justify-content:center;color:#d6246e;font-size:18px\">\u270e<\/span><span style=\"background:#d6246e;color:#fff;font-weight:700;border-radius:30px;padding:9px 22px;font-size:16px\">\u00d6neri G\u00f6nder<\/span><\/a><\/p>\n\n","protected":false},"excerpt":{"rendered":"<p>TATD-AKOM KL\u0130N\u0130K UYGULAMA REHBER\u0130 \u00b7 TASLAK MET\u0130N T\u00fcrkiye Acil T\u0131p Derne\u011fi \u2013 Ara\u015ft\u0131rma Komitesi (TATD-AKOM) taraf\u0131ndan 2026 y\u0131l\u0131nda haz\u0131rlanm\u0131\u015ft\u0131r. Yazar KomitesiErsin Aksay,&hellip;<\/p>\n","protected":false},"featured_media":2319,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"_lmt_disableupdate":"","_lmt_disable":"","_tatd_show_on_main_site":"","footnotes":""},"categories":[1,10011,10019],"tags":[],"class_list":["post-2321","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-genel","category-haber-ve-duyuru","category-klinik-uygulama-rehberleri"],"acf":[],"_links":{"self":[{"href":"https:\/\/tatd.org.tr\/arastirma\/wp-json\/wp\/v2\/posts\/2321","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/tatd.org.tr\/arastirma\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/tatd.org.tr\/arastirma\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/tatd.org.tr\/arastirma\/wp-json\/wp\/v2\/comments?post=2321"}],"version-history":[{"count":0,"href":"https:\/\/tatd.org.tr\/arastirma\/wp-json\/wp\/v2\/posts\/2321\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/tatd.org.tr\/arastirma\/wp-json\/wp\/v2\/media\/2319"}],"wp:attachment":[{"href":"https:\/\/tatd.org.tr\/arastirma\/wp-json\/wp\/v2\/media?parent=2321"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/tatd.org.tr\/arastirma\/wp-json\/wp\/v2\/categories?post=2321"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/tatd.org.tr\/arastirma\/wp-json\/wp\/v2\/tags?post=2321"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}